In summary, MEF2C increases expression of multiple factors that maintain pulmonary vascular homeostasis, MEF2C activity is impaired in PAH, and class IIa HDAC inhibition can restore its function. This evidence concerns the gene MEF2C and pulmonary arterial hypertension.